Protocols for Improved in Vitro Fertilization (IVF) Outcomes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00334243 |
Recruitment Status :
Terminated
(stopped due to limited enrollment. 2 subjects were enrolled. There was NO enrollment after November 2007.)
First Posted : June 7, 2006
Last Update Posted : October 6, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Infertility | Drug: Microflare protocol for IVF Drug: Antagonist protocol for IVF Drug: Demi-halt protocol for IVF | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 2 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Protocol Evaluation for Improved In Vitro Fertilization Outcomes |
Study Start Date : | June 2006 |
Actual Primary Completion Date : | August 2007 |
Actual Study Completion Date : | November 2007 |
- Pregnancy Rate
- Cycle Cancellation Rates
- Number of Oocytes Generated
- Number of Embryos Generated
- Serum hormonal evaluation
- Follicular fluid evaluation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Infertile patients
- Undergoing IVF
- Antral Follicle Count Less than 10
- Prior history of less than 5 oocytes generated during an IVF cycle

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00334243
United States, California | |
University of California, San Francisco | |
San Francisco, California, United States, 94115 |
Principal Investigator: | Marcelle I Cedars, MD | University of California, San Francisco |
Responsible Party: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT00334243 |
Other Study ID Numbers: |
Purcell-01 |
First Posted: | June 7, 2006 Key Record Dates |
Last Update Posted: | October 6, 2011 |
Last Verified: | October 2011 |
in vitro fertilization infertile infertility pregnancy pregnancy rates microflare protocol antagonist protocol |
demi-halt protocol poor responders low antral follicle count Infertile Patients undergoing in vitro fertilization (IVF) Patients with a previous poor response to ovarian stimulation Patients with an antral follicle count of less than 10 |
Infertility |